BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15777655)

  • 1. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice.
    Nakamura Y; Tensho K; Nakaya H; Nawata M; Okabe T; Wakitani S
    Bone; 2005 Mar; 36(3):399-407. PubMed ID: 15777655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation.
    Nakamura Y; Wakitani S; Nakayama J; Wakabayashi S; Horiuchi H; Takaoka K
    J Bone Miner Res; 2003 Oct; 18(10):1854-62. PubMed ID: 14584896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
    Fakhry A; Ratisoontorn C; Vedhachalam C; Salhab I; Koyama E; Leboy P; Pacifici M; Kirschner RE; Nah HD
    Bone; 2005 Feb; 36(2):254-66. PubMed ID: 15780951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity.
    Tanaka E; Ishino Y; Sasaki A; Hasegawa T; Watanabe M; Dalla-Bona DA; Yamano E; van Eijden TM; Tanne K
    Ann Biomed Eng; 2006 May; 34(5):717-25. PubMed ID: 16568346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
    Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
    J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation.
    Someya A; Yuyama H; Fujimori A; Ukai M; Fukushima S; Sasamata M
    Eur J Pharmacol; 2006 Aug; 543(1-3):14-20. PubMed ID: 16843458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region- and stage-specific effects of FGFs and BMPs in chick mandibular morphogenesis.
    Mina M; Wang YH; Ivanisevic AM; Upholt WB; Rodgers B
    Dev Dyn; 2002 Mar; 223(3):333-52. PubMed ID: 11891984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of BMP-induced ectopic bone formation by Ahsg.
    Rittenberg B; Partridge E; Baker G; Clokie C; Zohar R; Dennis JW; Tenenbaum HC
    J Orthop Res; 2005 May; 23(3):653-62. PubMed ID: 15885488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery.
    Jeon O; Song SJ; Yang HS; Bhang SH; Kang SW; Sung MA; Lee JH; Kim BS
    Biochem Biophys Res Commun; 2008 May; 369(2):774-80. PubMed ID: 18313401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
    Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
    Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs).
    Quarto N; Wan DC; Longaker MT
    Bone; 2008 Jun; 42(6):1040-52. PubMed ID: 18420480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice.
    Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
    Biochem Biophys Res Commun; 2007 Mar; 354(2):453-8. PubMed ID: 17239347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
    Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
    Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
    Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats.
    Kakudo N; Kusumoto K; Kuro A; Ogawa Y
    Wound Repair Regen; 2006; 14(3):336-42. PubMed ID: 16808813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo.
    Zhou H; Qian J; Wang J; Yao W; Liu C; Chen J; Cao X
    Biomaterials; 2009 Mar; 30(9):1715-24. PubMed ID: 19131102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
    Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
    J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of BMP-2 and -4 for rat mandibular bone regeneration at various doses.
    Arosarena O; Collins W
    Orthod Craniofac Res; 2005 Nov; 8(4):267-76. PubMed ID: 16238607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.